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Purpose:  To  address  the  roles  of  the  stromal  derived  factor-1  (SDF-1)  α  in  the  course  of  experimental  corneal
neovascularization (CNV).
Methods: CNV was induced by alkali injury and compared in SDF-1α- or vehicle-treated mice two weeks after injury.
Angiogenic factor expression in the early phase after injury was quantified by reverse transcription polymerase chain
reaction (RT-PCR). Progenitor cell, macrophage, and monocyte intracorneal accumulation in the early phase after injury
was evaluated by flow cytometric analysis.
Results: The mRNA expression of SDF-1α was augmented, together with infiltration of c-kit-positive progenitor cells in
the corneas after the alkali injury. Compared with vehicle-treated mice, SDF-1α-treated mice exhibited enhanced CNV
two weeks after injury, as evidenced by enlarged cluster of differentiation 31 (CD31)-positive areas. Concomitantly, the
intracorneal  infiltration  of  c-kit-positive  progenitor  cells  but  not  F4/80+  macrophages  or  Ly-6G+  monocytes  was
significantly enhanced in SDF-1α-treated mice compared to vehicle-treated mice. SDF-1α enhanced vascular endothelial
growth factor (VEGF) expression by murine peritoneal macrophages. Enhancement in intraocular VEGF expression was
greater in SDF-1α-treated mice than in control mice after injury. Moreover, local administration of C-X-C chemokine
receptor type 4 (CXCR4) antagonist after alkali injury reduced alkali-induced CNV.
Conclusions: SDF-1α-treated mice exhibited enhanced alkali-induced CNV through enhanced intracorneal progenitor
cell infiltration and increased VEGF expression by macrophages.
The  cornea  is  characterized  by  the  absence  of  blood
vessels and hematopoietic cells including erythrocytes and
leukocytes  under  physiologic  conditions  [1].  Corneal
avascularity is required for optical clarity and maintenance of
vision. Corneal neovascularization (CNV) arises from many
causes including corneal infections, misuse of contact lens,
chemical  burn,  and  inflammation,  and  can  lead  to  severe
impaired vision [2-4]. Under most of these conditions, bone
marrow (BM)-derived cells, neutrophils, and macrophages
infiltrate the cornea. We previously proved that experimental
CNV can occur independently of granulocyte infiltration [5].
Moreover, we observed that infiltrated macrophages exert
complicated roles, by using different chemokine receptor and
proinflammatory signals in the development of CNV [6-9].
The chemokine receptor, C-X-C chemokine receptor type
4 (CXCR4), was initially cloned as an orphan chemokine
receptor and was found to be expressed on many different cell
types such as monocytes, lymphocytes, hematopoietic and
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endothelial progenitor cells [10-13]. CXCR4 is activated by
its single ligand, stromal-derived factor 1 (SDF-1/CXCL12),
and mediates several different activities such as chemotaxis,
adhesion, proliferation, survival, and, in some cells, apoptosis
[14]. Activation of CXCR4 on lymphocytes and monocytes
stimulates  chemotaxis,  resulting  in  recruitment  to  sites  of
immune and inflammatory reactions.
Accumulating evidence suggests that CXCR4/SDF-1α
axis  is  involved  in  neovascularization.  CXCR4  is  also
detected in endothelial cells [15]. Jin et al. [16] reported the
involvement of SDF-1α in revascularization of ischemic hind
limbs  through  recruitment  of  CXCR4+  hemangiocytes.
Subcutaneous SDF-1α injection into mice induces infiltration
of  leukocytes  such  as  monocytes/macrophages  and  small
areas of neovascularization (NV) [17]. This enhanced NV
may occur due to angiogenic factor expression by monocytes/
macrophages. The CXCR4/SDF-1α axis plays a central role
in  the  development  of  several  types  of  ocular
neovascularization  including  choroidal  neovascularization,
diabetic  retinopathy,  and  oxygen-induced  ischemic
retinopathy [18-23]. Moreover, several independent studies
suggest  that  SDF-1α  may  be  responsible  for  abnormal
vasculature in the posterior segment of the eye. BM-derived
endothelial  precursor  cells  (EPCs)  have  previously  been
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2129shown  to  contribute  to  choroidal  neovascularization  by
signaling  through  the  SDF-1α/CXCR4  axis  [24-26].
Moreover,  mature  vascular  endothelial  cells  also  express
CXCR4 and its expression is upregulated by inflammatory
cytokines and angiogenic factors including fibroblast growth
factor (FGF) 2 and vascular endothelial growth factor (VEGF)
[17,27-29]. Furthermore, Yu and colleagues [30] detected
CXCR4  expression  on  human  retinal  microvascular
endothelial  cells  associated  their  invasion  and  tubule
formation.
The  roles  of  the  SDF-1α/CXCR4  axis  in  mediating
corneal neovascularization subsequent to severe injury remain
unclear. To further address the roles of CXCR4 signal in
ocular neovascularization, the process of alkali-induced CNV
was analyzed in SDF-1α- or CXCR4 antagonist-treated mice
in comparison with control-treated mice. Here, we provided
the  definitive  evidence  to  indicate  the  critical  role  of
SDF-1α-induced  progenitor  cell  recruitment  and  VEGF
production by infiltrated macrophages in the experimental
corneal neovascularization.
METHODS
Reagents and antibodies: Rat anti-mouse F4/80 (clone A3–1)
monoclonal  antibody  (mAb)  was  obtained  from  Serotec
(Oxford, UK). Rat anti-mouse CD31 (MEC13.3), anti-mouse-
Ly-6G (Clone IA8, catalog no. 551495) mAbs were purchased
from BD PharMingen (San Diego, CA). Goat anti-mouse c-
kit  (AF1356)  antibody  and  recombinant  mouse  SDF-1α
(catalog no. 460-SD/CF) were supplied by R&D Systems
(Minneapolis,  MN).  Goat  anti-mouse  VEGF  (sc-1836)
polyclonal  antibodies  and  CXCR4  antagonist  (AMD3100,
SC-252367)  were  from  Santa  Cruz  Biotechnology  (Santa
Cruz, CA).
Mice: Specific pathogen-free 7 to 8 weeks old male BALB/c
mice weighing 20 to 25 g were obtained from Shanghai SLAC
Laboratory Animal Co. Ltd (Shanghai, China) and were kept
in our animal facility under specific pathogen-free conditions.
All animal experiments were done in accordance with the
Guideline for the Care and Use of Laboratory Animals on the
Chinese  Medical  Academy  and  the  Soochow  University
Animal Care Committee, and with the ARVO Statement for
the  Use  of  Animals  in  Ophthalmic  and  Vision  Research.
Animals were kept in groups of 5 and fed regular laboratory
chow and water ad libitum. A 12-h day and night cycle was
maintained.
Alkali-induced  corneal  injury  model:  Corneal  injury  was
induced by placing a 2-mm filter disc saturated with 1N NaOH
onto the left eye of the mouse for 45 s as previously described
[5-9]. SDF-1α was dissolved in 0.2% sodium hyaluronate
(Sigma-Aldrich, St. Louis, MO) immediately before topical
application.  In  some  experiments,  the  alkali-treated  eyes
received  5  μl  of  SDF-1α  dissolved  in  0.2%  sodium
hyaluronate at a concentration of 5 μg/ml, or 5 μl of 0.2%
sodium  hyaluronate  as  vehicle  twice  a  day  for  7  days
immediately  after  the  alkali  injury.  In  another  series  of
experiments, the eyes were treated with alkali for 45 s and
received 5 μl of CXCR4 antagonist at a concentration of
100 μg/ml, or 5 μl of 0.2% sodium hyaluronate as vehicle
twice a day for 7 days immediately after the alkali injury. At
the indicated time intervals, mice were sacrificed, and whole
eyes were removed. The eyes were snap-frozen in optimal
cutting  temperature  (OCT)  compound  for  histological
analysis, or the corneas were removed and placed immediately
into RNALate (Qiagen, Tokyo, Japan), and kept at −86 °C
until total RNA extraction was performed. Each experiment
was repeated at least three times.
Biomicroscopic examination: Eyes were examined under a
surgical microsystem (Leica MZ16, Wetzlar, Germany) 14
days after alkali injury by two independent observers with no
prior knowledge of the experimental procedures, as described
previously [6-9].
Flow  cytometrical  analysis  of  intracorneally  infiltrating
progenitor cells, macrophages and monocytes: Mononuclear
cells were isolated from corneas according to the procedure
described previously with some modifications [6]. Briefly, at
4 days after the alkali injury, corneas were removed, were
teased away with scissors, and were incubated at 37 °C for 30
min  with  constant  shaking  in  the  presence  of  0.5  mg/ml
collagenase  type  D  (Roche  Diagnostics,  Mannheim,
Germany). Cell suspensions were then passed over a nylon
filter with 100-µm pore size. The resultant cells were further
stained with goat anti-c-kit Ab following by staining with
FITC-conjugated rat anti-goat IgG mAb. In another series of
experiments, the resultant cells were stained with rat anti-
mouse F4/80 or rat anti-mouse Ly-6G Ab followed by staining
with PE-conjugated swine anti-rat IgG mAb. Fluorescence
intensities were determined with the help of FACS Calibur
(Becton Dickinson, Franklin Lakes, NJ), together with the
samples stained with non-immunized goat or rat IgG (Sigma
Aldrich) as an isotype control.
Enumeration  of  corneal  neovascularization:  The  fixed
cryosections  (8-µm  thick)  were  stained  using  anti-CD31
mAb. The numbers and sizes of the CNV were determined as
described previously [6-9], by an examiner with no previous
knowledge of the experimental procedures. Briefly, images
were captured with a digital camera and imported into Adobe
Photoshop.  Then,  the  numbers  of  neovascular  tubes  per
mm2,  and  the  proportions  of  CNV  in  the  hot  spots  were
determined using NIH Image analysis software version 1.62
(National Institutes of Health, Bethesda, MD). Most sections
were taken from the central region of the cornea. The numbers
and areas of corneal neovascularization were evaluated on at
least two sections from each eye.
Semi-quantitative  reverse  transcription  (RT)-polymerase
chain reaction (PCR): Total RNAs were extracted from the
corneas or cultured macrophages with the use of RNeasy Mini
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were further treated with RNase-free DNase (DNase) I (Life
Technologies Inc., Gaithersburg, MD) to remove genomic
DNA. Two μg of total RNAs were reverse-transcribed at 42 °C
for 1 h in 20 μl of reaction mixture containing mouse Moloney
leukemia  virus  reverse  transcriptase  and  hexanucleotide
random primers (Qiagen). Serially twofold diluted cDNA was
amplified  for  β-actin  (Actb)  to  estimate  the  amount  of
transcribed cDNA. Then, equal amounts of cDNA products
were amplified for the target genes using the primers under
the following conditions; denaturation at 94 °C for 2 min,
followed by the optimal cycles of 30 s at 94 °C, 45 s at 55–
58 °C, 1 min at 72 °C, and a final 10 min extension step at
72 °C. Sequences of the primers and PCR conditions were
listed  in  Table  1.  The  amplified  PCR  products  were
fractionated on a 1.0% agarose gel and visualized by ethidium
bromide staining. The band intensities were measured and
their ratios to Actb were determined with the aid of NIH
Image analysis software.
Western blot analysis: Corneal cell lysates were prepared
from the indicated time interval after alkali injury. Protein
samples were dissolved in Laemmli buffer, boiled for 3–4
min,  and  centrifuged  for  2  min  at  20,000×  g  to  remove
insoluble materials. Protein (30 μg) per lane was separated by
sodium  dodecyl  sulfate  (SDS)/PAGE  (PAGE;  12%)  and
transferred to a 0.2 μm nitrocellulose membrane. The blocked
membranes were probed overnight (4 °C) with goat anti-
mouse  VEGF  antibodies  (sc-1836,  1:100;  Santa  Cruz
Biotechnology), and rabbit anti-mouse β-actin (N-21, 1:200;
Santa Cruz Biotechnology). Subsequently, the membranes
were  incubated  with  horseradish  peroxidase-conjugated
secondary  antibody,  and  immunoreactive  bands  were
visualized using ECL reagent (Pierce). Immunoreactive bands
corresponding to VEGF were quantified by Image J analysis
and normalized to those of β-actin.
Isolation  and  culture  of  murine  peritoneal  macrophages:
Peritoneal  macrophages  were  obtained  from  mice  as
described  previously  [6].  The  cells  were  suspended  in
antibiotic-free RPMI medium containing 10% fetal bovine
serum (FBS), and incubated in a humidified incubator at 37 °C
in  5%  CO2  in  6-well  cell  culture  plates  (Nalge  Nunc
International Corp., Naperville, IL). Two hours later, non-
adherent cells were removed, and the medium was replaced.
The  cells  were  then  stimulated  with  the  indicated
concentrations of murine SDF-1α for 12 h. Total RNAs were
extracted from the cultured cells and subjected to RT–PCR as
described  above.  In  another  series  of  experiments,  for  an
immunocytochemical analysis of VEGF expression, murine
macrophages  were  seeded  onto  the  wells  of  a  Lab-Tec
chamber slide with eight wells (Nalge Nunc) at 5×104 cells/
well. After non-adherent cells were removed, the cells were
stimulated with 100 μg/ml of murine SDF-1α for 12 h in a
37  °C  incubator  with  5%  CO2  and  then  subjected  to
immunocytochemical study as previous described [31]. To
TABLE 1. SEQUENCES OF THE PRIMERS USED FOR REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION.






ADAMTS-1 (F) CAGTACCAGACCTTGTGCAGACCTT 299 58 37
  (R) CACACCTCACTGCTTACTGGTTTGA      
SDF-1α (F) TGCCCCTGCCGGTTCTTCGAG 311 58 37
  (R) CTGTTGTTGTTCTTCAGCCGTGCAA      
VEGF (F) CTGCTGTACCTCCACCATGCCAAGT 509 57 37
  (R) CTGCAAGTACGTTCGTTTAACTCA      
TGF-β (F) CGGGGCGACCTGGGCACCATCCATGAC 405 57 37
  (R) CTGCTCCACCTTGGGCTTGCGACCCAC      
MMP-2 (F) GAGTTGGCAGTGCAATACCT 666 57 38
  (R) GCCATCCTTCTCAAAGTTGT      
MMP-9 (F) AGTTTGGTGTCGCGGAGCAC 754 57 37
  (R) TACATGAGCGCTTCCGGCAC      
TNF-α (F) CAGCCTCTTCTCATTCCTGCTTGTG 511 58 36
  (R) CTGGAAGACTCCTCCCAGGTATAT      
TSP-1 (F) ACCAAAGCCTGCAAGAAAGA 311 57 37
  (R) ATGCCATTTCCACTGTAGCC      
TSP-2 (F) CAGAGTACTGGCGTCGGTCA 649 57 37
  (R) ATAAGATCGCAGCCCACATACAG      
CXCR4 (F) ATGTAGACACTGGCGGAAATGG 459 57 37
  (R) AGGTGGGGCGAAAGGAAAC      
Actb (F) TGTGATGGTGGGAATGGGTCAG 514 55 25
  (R) TTTGATGTCACGCACGATTTCC      
        All primers used were purchased from Genset Oligos (Kyoto, Japan). The amplification was performed using a GeneAmp®
        PCR System 9700 (Perkin-Elmer, Foster City, CA). In the table, "F" indicates forward primer and "R" indicates reverse primer.
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2131test  the  expression  of  CXCR4  from  the  peritoneal
macrophages by flow cytometrical analysis, cells were stained
with rat anti-mouse F4/80 mAb and rabbit anti-mouse CXCR4
Ab followed by staining with FITC-conjugated goat anti-
rabbit IgG mAb and phycoerythrin (PE)-conjugated swine
anti-rat IgG mAb. Fluorescence intensities were determined
with the help of FACS Calibur (Becton Dickinson), together
with the samples stained with rat anti-mouse F4/80 mAb and
non-immunized rabbit IgG as a control.
Statistical analysis: The means and standard errors of the
mean (SEM) were calculated for all parameters determined in
the study. Data were analyzed statistically using one-way
ANOVA (ANOVA), or two-tailed Student’s t-test. A value of
p<0.05 was considered statistically significant.
RESULTS
Intracorneal SDF-1α mRNA expression after alkali-induced
corneal injury: We first examined SDF-1α mRNA expression
in corneas after alkali-induced corneal injury. SDF-1α mRNA
was  faintly  detected  in  untreated  eyes,  but  was  markedly
increased after alkali injury (Figure 1A,B). The enhanced
intracorneal  SDF-1α  mRNA  expression  prompted  us  to
investigate the possible involvement of the SDF-1α-CXCR4
interactions in alkali-induced CNV.
Effects of SDF-1α on alkali-induced CNV: We next explored
the  effects  of  SDF-1α  on  alkali-induced  CNV.  CNV  was
Figure 1. SDF-1α mRNA expression in corneas after alkali injury.
A: Semi-quantitative RT–PCR to evaluate mRNA expression of
SDF-1α. Corneas were harvested at the indicated time points, and
five corneas at each time point were pooled to extract total RNAs.
RT–PCR was performed using the obtained total RNAs. B: The ratios
of SDF-1α to Actb mRNA were determined. All values represent
mean±SEM of three to five independent measurements.
macroscopically evident in mice 2 weeks after the injury,
consistent  with  our  previous  reports  [5-9].  Macroscopic
inspection  demonstrated  that  untreated  corneas  were
avascular,  but  that  alkali  injury  markedly  increased  the
vascular areas in corneas to a larger extent in SDF-1α-treated
mice  than  vechicle-treated  ones  (Figure  2A).
Immunohistochemical analysis using anti-CD31 antibodies
further  revealed  that  CD31-positive  areas  were  larger  in
SDF-1α-treated mice than in vehicle-treated ones (Figure 2B-
E). These observations indicate that the SDF-1α-CXCR4 axis
could promote alkali-induced CNV.
Enhanced  c-kit+  progenitor  cell  infiltration  in  the  wound
corneas in SDF-1α treated mice: We previously observed that
Ly-6G-positive  granulocytes  and  F4/80-positive
Figure 2. The effects of SDF-1α on Alkali injury-induced CNV. A:
Macroscopic  appearance  of  vehicle-  or  SDF-1α-treated  BABL/c
mouse eyes 2 weeks after alkali injury. B: Corneal tissues were
obtained  2  weeks  after  injury  from  vehicle-  or  SDF-1α-treated
BABL/c  mice.  Tissues  were  immunostained  with  anti-CD31
antibody, and representative results from five to eight animals are
shown here. Original magnifications, 200×. Scale bar, 50 μm. C:
CNV numbers per square millimeter in whole section. D: CNV
numbers per square millimeter in hot spots. E: Proportions of CNV
areas in hot spots were determined from the corneas obtained from
vehicle- or SDF-1α-treated BABL/c mice 2 weeks after injury. Each
value represents mean±SEM (n=5–8 animals). *, p<0.05 compared
with vehicle-treated mice.
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2132macrophages  infiltrated  the  injured  cornea,  reaching  their
peak levels two to four days after the injury in mice [6].
Ly-6G-positive  granulocytes  and  F4/80-positive
macrophages  infiltrated  corneas  to  a  similar  extent  in
SDF-1α- and vehicle-treated mice after the injury (Figure 3,
Table  2).  On  the  contrary,  c-kit-positive  progenitor  cell
infiltration was markedly augmented in SDF-1α-treated mice
compared with vehicle-treated ones (Figure 3, Table 2). These
observations would indicate that SDF-1α treatment further
augmented  alkali-induced  infiltration  of  c-kit-positive
progenitor  cells  and  that  macrophages  infiltrated  as  a
consequence of injury rather than as a consequence of topical
administration SDF-1α.
Enhanced VEGF expression in SDF-1α-treated mice after
alkali  injury:  The  balance  between  angiogenic  and  anti-
angiogenic factors determines the outcome of angiogenesis
processes  in  various  situations.  Hence,  we  examined  the
mRNA expression of angiogenic and anti-angiogenic factors
in corneas after alkali injury. Alkali injury enhanced mRNA
expression of various angiogenic associated factors, including
VEGF,  transforming  growth  factor  (TGF)-β,  matrix
metalloproteinase (MMP)-2, MMP-9, tumor necrosis factor
(TNF)-α,  a  disintegrin  and  membranous  thrombospondin
(ADAMTS)-1, thrombospondin (TSP)-1, and TSP-2, similarly
as we described previously. Among these factors that we
examined, only VEGF mRNA expression was augmented to
a larger extent in SDF-1α-treated mice than vehicle-treated
ones  in  the  early  phase  after  injury  (Figure  4A,B).
Consistently,  intraocular  VEGF  protein  expression  was
increased to a larger extent in SDF-1α-treated mice compared
to  vehicle-treated  ones  (Figure  4C,D).  Thus,  exogenous
administration of SDF-1α augmented the expression of a pro-
angiogenic  factor,  VEGF,  thereby  tipping  the  balance  to
promote angiogenesis.
Enhanced VEGF expression by murine macrophages with
SDF-1α  stimulation:  To  delineate  the  roles  of  CXCR4
expression on macrophages, we next examined the effects of
SDF-1α on the expression of VEGF by macrophages. We
detected CXCR4 mRNA on murine peritoneal macrophages
by RT–PCR (data not shown) and flow cytometric analysis
detected  CXCR4  expression  on  37.5%–60.7%  of  F4/80-
positive  cells  (Figure  5A).  SDF-1α  markedly  enhanced
VEGF mRNA expression by peritoneal macrophages in a
dose-dependent  manner  (Figure  5B,C).  Consistently,
SDF-1α  augmented  VEGF  protein  expression  by
macrophages (Figure 5D). These observations would indicate
that SDF-1α can induce macrophages to express a potent
angiogenic  molecule,  VEGF,  through  the  interaction  with
CXCR4.
Topical  administration  of  CXCR4  antagonist  attenuated
alkali injury induced corneal neovascularization in WT mice:
Figure 3. c-kit-, F4/80- or Ly-6G-positive cell numbers in cornea
after alkali injury. Corneal tissues were obtained 4 days after injury
from vehicle- or SDF-1α-treated BABL/c mice, and the tissues from
7 to 8 mice were combined and were subjected to analysis using a
flow  cytometer  after  being  immunostained  with  anti-c-kit,  anti-
F4/80, or anti-Ly-6G antibody. Isotype IgG derived from the same
species  of  the  test  antibody  was  used  as  negative  control.
Representative  results  from  three  to  four  tests  of  intracorneal
infitlration of c-kit- (A), F4/80- (B), or Ly-6G-positive cells (C) from
either vehicle- (left plot) or SDF-1α-treated mice (right plot) are
shown.
TABLE 2. SDF-1Α TOPICAL ADMINISTRATION ON INTRACORENAL CELL INFILTRATION.
Target protein Control SDF-1α p value (F test)
C-Kit 3.08±0.37 9.85±1.58 <0.05
F4/80 5.20±0.38 7.73±0.49 >0.05
Ly-6G 12.37±1.36 12.97±1.32 >0.05
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2133Finally, we examined the effects of topically-applied CXCR4
antagonist on alkali-induced CNV. Topical administration of
CXCR4 antagonist in the early phase from day 1 to day 7 after
alkali injury significantly attenuated the alkali-induced CNV
compared to those of vehicle treatment (Figure 6). These
results further suggest that the crucial involvement of the
endogenously produced SDF-1α in alkali-induced CNV.
DISCUSSION
SDF-1α is a member of the CXC chemokine subfamily and is
presumed to be involved in BM progenitor cells migration
[32]. The reported contribution of BM-derived endothelial
progenitor cells to the choroidal neovascularization [24-26,
33] prompted us to speculate that SDF-1α may enhance CNV
by recruiting progenitor cells to the injured corneas. Indeed,
we observed increased intracorneal SDF-1α expression after
alkali injury, and local administration of SDF-1α enhanced
intracorneal  c-kit-positive  progenitor  cell  infiltration.
Accumulating  evidence  indicates  that  BM-derived  c-kit-
positive  cells  can  differentiate  into  endothelial  cells,  and
enhance neovascularization [34]. Thus, it is reasonable to
speculate that SDF-1α enhanced intracorneal c-kit-positive
cell infiltration, thereby augmenting alkali-induced CNV.
Figure 4. VEGF expression in the injured corneas of mice. A: Semi-
quantitative  RT–PCR  to  evaluate  mRNA  expression  of  VEGF.
Corneas were harvested at the indicated time points, and five corneas
at each time point were pooled to extract total RNAs. RT–PCR was
performed using the obtained total RNAs. Representative results
from three independent are shown here. B: The ratios of VEGF to
Actb mRNA were determined on vehicle- (open bars) and SDF-1α-
treated BABL/c mice (black bars). All values represent mean±SEM
of three to five independent measurements. C: Protein extracts were
obtained and subjected to western blotting analysis. Representative
results  from  three  independent  experiments  are  shown  here.  D:
Ratios of VEGF to β-actin protein bands of vehicle- (open bars) and
SDF-1α-treated mice (black bars) were determined as described in
Methods.  All  values  represent  mean±SEM  (n=5–8  animals).  *,
p<0.05 and #, p<0.01 compared with vehicle-treated mice.
Cornea avascularity is maintained by the balance between
angiogenic  and  anti-angiogenic  factor  expression  [2-4,35,
36].  Corneal  wounding  enhanced  predominantly  the
expression of angiogenic factors such as VEGF and basic
fibroblast growth factor (bFGF) [37], and skewed the balance
toward pro-angiogenic milieu, thereby causing CNV [38,39].
We observed that the expression of a potent angiogenic factor,
VEGF,  in  alkali-injured  cornea  was  enhanced  to  a  larger
extent when the mice were treated with SDF-1α, consistent
Figure  5.  SDF-1α-induced  VEGF  production  by  peritoneal
macrophages.  A:  CXCR4  expression  on  F4/80-positive  murine
peritoneal  macrophages  was  determined  by  a  flow  cytometric
analysis. Purified mononuclear cells were stained with rat anti-mouse
F4/80 mAb and rabbit anti-CXCR4 Abs (filled histogram) or rat anti-
mouse F4/80 mAb and non-immunized rabbit IgG (open heavy-lined
histogram) as a control followed by staining with FITC-conjugated
goat  anti-rabbit  IgG  and  PE-conjugated  swine  anti-rat  IgG.  A
representative result from three independent experiments is shown.
B: Peritoneal macrophages from WT mice were incubated with the
indicated concentrations of SDF-1α for 12 h. Quantitative RT–PCR
was performed on total RNAs extracted from the macrophages as
described in Methods. Representative results from 3 independent
experiments  are  shown  here.  C:  VEGF  mRNA  levels  were
determined  and  normalized  to  Actb  mRNA  levels.  Each  value
represents  the  mean  and  SEM  (n=3).  #,  p<0.01  compared  with
untreated.  D:  VEGF  protein  expression  was  detected  by
immunocytochemical analysis using anti-VEGF Abs as described in
Methods. Representative results from three independent experiments
are shown. Original magnification, 400×. Scale bar, 50 μm.
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2134with the previous report that the CXCR4/SDF-1α axis can
induce Akt phosphorylation and eventually augment VEGF
expression at both the mRNA and protein levels, thereby
promoting  VEGF-mediated  tumor  angiogenesis  [40].
Moreover, accumulating evidence indicates that VEGF can
stimulate  SDF-1α-induced  angiogenesis  [17,22,41],  by
enhancing  recruitment  of  CXCR4-expressing  BM-derived
progenitor cells [42-44]. Thus, our present observation raised
the possibility that SDF-1α and VEGF form a vicious cycle,
promoting alkali-induced CNV, particularly in its early phase.
Accumulating  evidence  indicates  that  BM-derived
progenitor cells (EPCs) can differentiate into endothelial cells
and contribute to the choroidal neovascularization [24-26]. It
is  also  likely  that  EPCs  can  contribute  to  corneal
neovascularization. The CXCR4-SDF-1α axis can control the
differentiation of EPCs to endothelial cells [45,46]. Moreover,
human  retinal  microvascular  endothelial  cells  express
CXCR4 and exhibit tube formation and migration in response
to SDF-1α [30,47]. These observations suggest that SDF-1α
can induce EPC infiltration into cornea, its differentiation into
endothelial  cells,  and  affect  the  functions  of  the  resultant
endothelial  cells  in  corneal  neovascularization.  Because
VEGF can increase CXCR4 expression on endothelial cells
[17,48],  VEGF  can  indirectly  enhance  neovascularization
through interacting the CXCR4/SDF-1α axis in addition to its
direct effects on neovascularization. These findings further
suggest  the  potential  role  of  the  interactions  between
SDF-1α and VEGF on CNV.
Several lines of evidence indicate that macrophages can
be pro-angiogenic by producing angiogenic factors in ocular
neovascularization [49-53]. We assumed that SDF-1α may
promote  neovascularization  by  inducing  macrophage
recruitment. In contrast to our expectation, topical SDF-1α
administration  failed  to  enhance  alkali  injury-induced
intracorneal  F4/80-positive  macrophage/monocyte
infiltration despite CXCR4 mRNA and protein expression by
Figure 6. The effects of CXCR4 antagonist on alkali-induced CNV.
CNV numbers per square millimeter in whole section (A), CNV
numbers per square millimeter in hot spots (B), and percentage CNV
areas in hot spots (C) were determined from the corneas obtained
from vehicle- or CXCR4 antagonist-treated BABL/c mice 2 weeks
after injury. Each value represents mean±SEM (n=5–8 animals).
p<0.05 compared with vehicle-treated mice.
a  substantial  proportion  of  monocytes/macrophages.  The
failure of SDF-1α to increase macrophage infiltration after
injury  could  be  due  to  saturation  of  the  CXCR4s  on
macrophages  by  their  ligand.  Alternatively,  full  signaling
activation  may  occur  if  only  some  of  the  receptors  are
occupied after alkali injury. Nevertheless, we observed that
SDF-1α induced murine peritoneal macrophages to produce
VEGF.  Thus,  the  SDF-1α-CXCR4  axis  can  be  crucial  to
VEGF production by CXCR4-expressing macrophages but
not monocyte/macrophage infiltration into cornea. Moreover,
CXCR4-positive  macrophages  can  be  pro-angiogenic
similarly to CCR2-expressing macrophages as we previously
reported [9].
The  administration  of  CXCR4  antagonist  remarkably
attenuated  alkali-induced  CNV,  indicating  the  crucial
involvement  of  endogenously  produced  SDF-1α  in  this
process. Age-related macular degeneration (AMD), an ocular
disease with choroidal neovascularization, is a leading cause
of  blindness  worldwide.  Lee  and  colleagues  reported  that
inhibition  of  SDF-1α  can  reduce  laser-induced  choroidal
neovascularization, a murine AMD model [23]. Guerin and
colleagues observed that SDF-1α, which may be produced by
the  RPE,  could  play  a  role  in  human  choroidal
neovascularization [54]. Furthermore, macrophages are found
to be present around neovascular areas in wet AMD patients
[55]. Considering that the SDF-1α-CXCR4 interactions can
regulate  pro-angiogenic  activities  of  macrophages,  it  is
tempting to speculate that the axis has a crucial role in AMD.
If so, blockade of this axis can be effective for treatment and/
or prevention of AMD.
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